INPLASY202530054

Clinical Benefit and Toxicity of mirvetuximab soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer：A systematic review and Single-Arm meta-analysis

Keywords: Platinum-Resistant，Ovarian Cancer，Mirvetuximab soravtansine，FRα-Positive.

Read and download full-text here - PDF 202630054

Review Status: completed but not published